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ABSTRACT 
International Journal of Exercise Science 14(3): 840-854, 2021. Polycystic ovary syndrome (PCOS), the 
most common chronic endocrinopathy and the leading cause of infertility in women, has significant clinical 
consequences, including cardiovascular, endocrinological, oncological, and psychological co-morbidities. 
Endocrine Society Clinical Practice Guidelines on the Diagnosis and Treatment of PCOS recommend exercise and 
physical activity as first-line treatment to combat chronic disease risk. However, details about what type of exercise 
are not provided. Given the known beneficial effects of resistance training on the management of other chronic 
diseases, the purpose of this scoping review was to evaluate the scientific evidence about the physical and 
psychosocial effects of resistance training among women with PCOS. Studies were identified through a systematic 
search of PubMed, SPORTDiscus, and CINAHL databases. Peer-reviewed research studies published between 
January 2011 and January 2021 that evaluated a resistance training intervention for premenopausal women with 
PCOS were included. Studies that offered multi-component programs were excluded. Nine articles met the 
inclusion criteria of which seven were sub-studies of one larger clinical trial. One article reported findings from a 
small randomized controlled trial and the last article reported feasibility study findings. Each intervention yielded 
positive results across a wide range of outcome variables; however, the studies had small sample sizes and assessed 
different outcome variables. Evidence regarding the effects of resistance training on health outcomes for women 
with PCOS is positive but preliminary. Adequately powered clinical trials are required to confirm health benefits, 
answer research questions as to therapeutic dose, and discover behavioral strategies to promote resistance training 
for therapeutic management.  
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Polycystic ovary syndrome (PCOS) is the most common chronic endocrinopathy and the leading 
cause of infertility in women (5). Based on conservative estimates, 5 million women in the United 
States (US) have PCOS (28). According to the 2003 Rotterdam diagnostic criteria, the most 
widely used criteria, PCOS is diagnosed when two or more of the following conditions are met: 
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ovulatory dysfunction or ultrasound evidence of polycystic ovaries, and clinical and/or 
biochemical signs of hyperandrogenism (23). The Endocrine Society endorses the 2003 
Rotterdam Criteria because these criteria require a more comprehensive evaluation than other 
criteria, as it is the only criteria to include ovarian morphology (23). Women with PCOS are at 
risk for insulin resistance, obesity (specifically, visceral adiposity), dyslipidemia, and 
endometrial disturbances, thereby increasing the likelihood of comorbidities such as metabolic 
syndrome, cardiovascular disease, and endometrial cancer (10). Psychological morbidities are 
also significant, as women with PCOS are eight times more likely to have anxiety and depression 
than women without PCOS (8, 34). Given its various definitions and phenotypes, as well as 
significant and varied comorbidities, optimal treatment and management typically involves a 
multi-pronged approach of targeted medications and weight-management lifestyle changes.  
  
Accordingly, the Endocrine Society Clinical Practice Guidelines on the Diagnosis and Treatment 
of PCOS recommend exercise and physical activity as first-line treatment to combat chronic 
disease risk yet details about what type of exercise are not included (23). Based on a 2011 
systematic review of aerobic exercise (e.g., walking, cycling) for women with PCOS, the PCOS 
Australian Alliance adult guidelines advised at least 150 minutes per week of moderate-
intensity physical activity, of which 90 minutes should be moderate-to-high intensity aerobic 
activity, to maintain health and/or help prevent chronic comorbidities by reducing body weight 
(1). The literature at that time had only examined the isolated use of aerobic exercise or aerobic 
exercise with diet. Therefore, any recommendations for resistance training are absent from these 
guidelines (38).   
  
Resistance training (RT) is the anaerobic category of exercise involving the repeated movements 
against unaccustomed loads to stimulate a stronger muscle contraction (38). There is a wealth of 
research describing the beneficial effects of RT on symptoms and management of several chronic 
diseases such as diabetes, cardiovascular disease, and cancer (7). Since muscle contraction 
involves both mechanical and metabolic properties (39), this exercise modality is associated with 
increased functional strength (40), improved insulin sensitivity, quicker rapid glucose uptake 
(38), clinically decreased blood pressure over time, and increased basal metabolic rate 
(responsible for approximately two thirds of total energy expenditure) (39). These benefits are 
the reasons cardiac rehabilitation programs now include RT (29). Additionally, in a study by 
Schmitz et al. (35) a sample of women aged 30-50 years lost more visceral fat than men after an 
intervention of RT. Visceral fat, a type of fat stored in the abdomen, is a typical PCOS symptom 
and associated with risk of metabolic syndrome, diabetes, and hypertension (9, 39). Thus, the 
myogenic or muscular adaptations induced by RT are often accompanied by a range of 
physiological (metabolic) and functional adaptations that may be clinically important among 
women with PCOS.   
 
A recent systematic review and meta-analysis also reported on the “discordant and limited 
findings on exercise characteristics” that could lead to more complete and detailed exercise 
guidelines for women with PCOS (9). This study reported on ten exercise interventions: eight 
aerobic, one RT, and one high-intensity training. The findings revealed high heterogeneity for 
major outcomes of reproductive function (menstrual cycle, ovulation, and fertility) and minor 
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outcomes such as body composition. The research team noted low certainty evidence for little 
to no effect of exercise on reproductive hormones and moderate certainty evidence that aerobic 
exercise reduced body mass index (BMI) in women with PCOS (9). Many studies, however, do 
not delineate what type of body mass is lost (fat weight vs. lean mass). If the women are losing 
lean muscle mass, the basal metabolic rate slows, producing diminishing returns over time. 
Aerobic exercise was also credited for improved cardiorespiratory function, whereas resistance 
training increased functional strength (9). The authors recommended further research on the 
benefits of the unique characteristics of exercise with more consideration for RT (9).  
  
Additionally, evidence exists that some women with PCOS are often dissatisfied with the typical 
medical model, including pharmaceutical treatment (e.g., metformin and birth control pills). 
These women report actively seeking alternative therapeutic management strategies such as 
acupuncture and herbal remedies (44). Despite the high prevalence and serious clinical 
implications of PCOS throughout the woman’s lifespan, no standard long-term treatment 
prevails, and current medications are only moderately effective at controlling symptoms and 
preventing complications (23). However, non-pharmacological therapeutic management 
strategies such as RT are relatively unexplored in women with PCOS. Exercise as therapeutic 
management will be defined as planned and structured movement designed to attenuate clinical 
symptoms of PCOS and reduce associated risk of comorbidities over the long-term. The 
objective of this scoping review was to present current literature specific to the isolated use of 
RT and delineate evidence of its effectiveness in this population. To the best of our knowledge, 





The search strategy was based on the Arksey and O’Malley (4) framework for scoping reviews. 
A search of PubMed, CINAHL, and SPORTDiscus was conducted. Search strategies for all 
databases were adapted from the PubMed search strategy (Table 1). Database searches were 
limited to the last 10 years (January 2011 – January 2021), as this time span is relevant given the 
publication of the Australian Physical Activity Guidelines in 2011 and the Endocrine Society 
Clinical Practice Guidelines in 2013. The search was also limited to full-text articles written in 
English. MeSH and TIAB terms were used for the database search (Table 1). This research was 
carried out fully in accordance with the ethical standards of the International Journal of Exercise 
Science (29).  
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Table 1. Concepts with MeSH and TIAB terms used for the database search.   
Concept  MeSH Term TIAB Terms 
Polycystic Ovary Syndrome  Polycystic Ovary Syndrome PCOS* 
   Polycystic ovar* 
Resistance Training  Resistance Training Resistance exercise* 
   Resistance training 
   Progressive resistance training 
   Strength training 
   Strengthening 
   Weight bearing 
   Weightlifting 
   Weight training 
   Exercise band 
   Medicine ball 
 
Articles were deemed eligible for review if they were published in a peer-reviewed journal 
between January 2011 and January 2021, reported the results of research that evaluated a RT 
intervention, and involved a sample of premenopausal women with PCOS. In all studies, the 
diagnosis of PCOS was determined by the 2003 Rotterdam Criteria and confirmed by either the 
participant’s general practitioner or specialist. Studies that offered multi-component programs 
(nutrition, aerobic exercise, and counseling) were excluded to assess the effects of the isolated 
use of RT. No studies were excluded based on age.   
  
The reviewer documented the number of articles at each stage of the screening process using the 
PRISMA flow diagram (Figure 1). Each eligible article was then reviewed for general content, 
results, and contribution to the literature.   
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Figure 1. PRISMA flowchart.  
As shown in Table 2, the following data were extracted from each article: study purpose, design, 
sample, intervention, measures, and results. We also present the potential benefits of RT for 
women with PCOS and offer recommendations for future research. The Johanna Briggs 
Institute’s Critical Appraisal Checklist was used to assess the methodological quality of each 
study (17).  
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Table 2. Summary of resistance training studies from January 2009-July 2020. The studies in the bold 
outlined box are sub-studies of a larger trial. 
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*Abbreviations: %BF = percent body fat, BMI = body mass index, CRP = c-reactive protein, FB = Facebook, HIT = 
high intensity training, HR = heart rate, HbA1C = glycated hemoglobin test, HOMA-IR = homeostatic model 
assessment of insulin resistance, LMM = lean muscle mass, PA = physical activity, PCOS = polycystic ovary 
syndrome, QOL = quality of life, ST = strength training TG = triglycerides, T chol = total cholesterol, UNK = 
unknown, WC = waist circumference, WHtR = waist to height ratio 
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Of the 52 articles identified from the selected databases, five were removed as duplicates and 31 
were removed based on titles and abstracts that indicated exclusion criteria. Of the remaining 
16 articles, full-text reviews yielded nine articles that matched criteria (Figure 1). Of these nine 
articles, seven were from the same parent study, a nonrandomized case-control study. The other 
two articles featured a randomized controlled trial and a nonrandomized feasibility study. Thus, 
these nine articles represent three separate interventions. The geographic location of these 
studies included Brazil, Norway, and Australia. Brazil was the site for the parent study (and 
hence, its six associated studies). Refer to Table 3 for the summary of the Johanna Briggs 
Institute’s Critical Appraisal Checklists using the research designs of three RT interventions. 
 
Table 3. Summary of the Johanna Briggs Institute’s Critical Appraisal Checklist using the RT intervention research 
designs. 
Checklist Item Kogure et al., 2015 (19) 
Almenning et 
al., 2015 (2) 
Vizza et al., 
2016 (37) 
Is it clear in the study what is the ‘cause’ and what is the 
‘effect’ (i.e. there is no confusion about which variable 
comes first)? 
Yes Yes Yes 
Were the participants included in any comparisons 
similar? 
Yes 
 Yes Yes 
Were the participants included in any comparisons 
receiving similar treatment/care, other than the 





3-arm parallel Yes 
Was there a control group? Yes Yes Yes 
Were there multiple measurements of the outcome both 
pre and post the intervention/exposure? Yes Yes Yes 
Was follow up complete and if not, were differences 
between groups in terms of their follow up adequately 
described and analyzed? 
Yes Yes Yes 
Were the outcomes of participants included in any 
comparisons measured in the same way? Yes Yes Yes 
Were outcomes measured in a reliable way? Yes Yes Yes 
Was appropriate statistical analysis used? Yes Yes Yes 
Overall Appraisal Include Include Include 
Note: The same research design was implemented in the six sub-studies, thus matching that of Kogure et al., 2015 
(18, 19, 20, 22, 25, 32, 33). 
 
Study sample sizes ranged from 15 to 73 participants; all participants were overweight or obese, 
sedentary, premenopausal women with PCOS in the age range of 18-42. In one randomized 
controlled trial, the participants’ age range was not mentioned; however, 26 years old was the 
mean age for the intervention group (2). In all three studies, the diagnosis of PCOS was 
confirmed by the participants’ primary care providers (2, 19, 37), and in two studies, PCOS was 
diagnosed using the 2003 Rotterdam criteria (2, 19). The larger randomized controlled trial and 
its associated studies (all based on secondary analysis of the parent study) included a control 
group of premenopausal sedentary and overweight or obese women who did not have PCOS 
(19). The study by Vizza et al. (37) included all women with PCOS; however, one group (n =8) 
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received progressive RT and the control group (n = 7) did not receive an intervention. The 
feasibility study included only women with PCOS but compared three types of exercise: high 
intensity training (n = 8), strength training (n = 8), and physical activity (n = 7) (2) (Table 2). High 
intensity training differs from strength training in terms of higher intensity and shorter duration. 
For example, high-intensity training involves shorter, more intense unsustainable bursts of 
physical activity, combined with short periods of rest, such as running sprints on the treadmill 
followed by a quick recovery period. In contrast those in the strength training group received 
an intervention consistent with progressive linear periodization, which involves anaerobic 
activity only at a slower pace. Physical activity is a type of aerobic (versus anaerobic) exercise 
defined by the World Health Organization as any body movement that requires more energy 
than rest (43).  
 
Terms used in the three interventions for RT include progressive resistance training and strength 
training. The protocol for all interventions was the same, that of progressive linear periodization. 
Periodization is a commonly used RT method involving planned manipulation of training 
variables (load, sets, and repetitions) to maximize neuromuscular adaptations to unaccustomed 
load or stressors. The linear model is based on changing exercise volume and load across several 
predictable mesocycles. Based on a 12-month period, the program is referred to as a macrocycle; 
the 2 subdivisions are the mesocycle (3-4 months) and the microcycle (1-4 weeks) (23). All the 
studies included interventions that progressed through a microcycle and into a mesocycle.  
  
The overall purpose of the studies was to examine the impact of RT among overweight or obese 
and sedentary premenopausal women with PCOS. The parent study and its six associated 
studies (one large non-RCT) each emphasized a different primary variable: lean muscle mass 
(19), sexual function (22), autonomic regulation of heart rate variability (33), quality of life (32), 
telomere content (25), muscle strength (20), and obesity indices (18). The study by Vizza et al. 
(37) was designed to assess the feasibility of executing a randomized controlled trial of 
progressive RT in women with PCOS. Although the primary outcomes were recruitment and 
attrition, adherence, adverse events and completion of assessments, secondary outcomes were 
also collected and included a range of biopsychosocial variables (37). Almenning et al. (2) aimed 
to measure metabolic (e.g., total cholesterol), cardiovascular (e.g., resting heart rate), and 
hormonal (e.g., free androgen index) outcomes from 10 weeks of strength training, high intensity 
training, or physical activity. Table 2 provides more detail as to purpose, study design, sample, 
intervention, measures, and results.  
 
Anthropometrics: Although each article focused on a different primary outcome, the articles also 
shared common secondary outcomes. For example, each study revealed a significant decrease 
in percent body fat due specifically to reduced visceral fat, thus decreased waist circumference. 
Visceral fat, that is abdominal adiposity, is an important predictor of obesity-related health risks 
such as cardiovascular and metabolic disorders (16). Visceral fat has also been implicated in the 
etiology of insulin resistance in PCOS (15). Additionally, each RT intervention produced a 
significant increase in lean muscle mass among women with PCOS when compared with other 
women with PCOS who served as control and with women without PCOS. The decrease in 
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percent body fat plus the increase in lean muscle mass equaled no change in body mass index 
for women with PCOS in the RT intervention groups. 
 
Metabolic: A common metabolic outcome measured in all studies was fasting glucose. This 
measure decreased with statistical significance after a program of RT in all studies. Interestingly, 
RT produced a significantly lower fasting glucose in women with PCOS as compared to women 
without PCOS who engaged in the same RT program (19). 
 
Hormonal: Each study involved biochemical assays to obtain a hormonal panel on each 
participant. The selected hormonal tests for each study’s panel differed with only two common 
variables: serum testosterone and sex hormone binding globulin (SHBG). Serum testosterone 
significantly decreased after a program of resistance training in two studies (19, 37) and did not 
change at all in the feasibility study (2), which was attributed to difficulty with interpretation 
within a small-scale study. Women with PCOS often present with below normal levels of SHBG, 
a glycoprotein that serves to limit exposure to androgen (31). Interestingly, the three main 
studies indicated mixed results: a decrease without statistical significance (37), an increase with 
statistical significance (19), and no change at all (2). 
 
Almenning et al. (2) was the only study to consider anti-Mullerian hormone (AMH), a 
glycoprotein often used as a measure of certain aspects of ovarian function. Evidence has shown 
that increasing the level of AMH improves fertility due to its inhibitory effect on follicular 
sensitivity to follicle-stimulating hormone (6). In the study by Almenning et al. (2), women with 
PCOS had a significant decrease in AMH after a program of resistance training, high intensity 




Endocrine Society Clinical Practice Guidelines on the Diagnosis and Treatment of PCOS 
recommend exercise and physical activity as first-line treatment to combat the risk of chronic 
comorbidities. However, detail about the type of exercise is not provided. The scientific 
literature includes information about cardiovascular or aerobic activity, but notably lacks 
attention to RT. Given the known beneficial effects of RT on the management of other chronic 
diseases, RT may provide therapeutic management for PCOS.  
  
A scoping review of three databases over the last ten years revealed nine articles that involved 
three interventions. The primary outcomes of each intervention shared broad categories of 
anthropometric, hormonal, cardiovascular, and fitness variables. Common outcome measures 
across all three interventions that resulted in positive and significant changes after RT included 
waist circumference, percent bodyfat, lean muscle mass, testosterone, sex hormone binding 
globulin, and fasting glucose. Kogure et al. (18) and Vizza et al. (37) measured waist 
circumference as an operational definition for central adiposity, whereas Almenning et al. (2) 
used percent bodyfat to operationalize total body fat mass. Although percent bodyfat is the best 
measure for overall obesity, central adiposity is associated with a greater risk for chronic disease 
(11). Further, a distinction must be made between types of body mass. The body mass index is 
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a function of bodyweight and height. Schmitz et al. (35) found that sedentary, overweight 
women lost a significant amount of visceral fat after a RT intervention. In Kogure et al. (19), 
findings revealed that women with PCOS had no change in body mass index; however, lean 
muscle mass increased. Logistically, this indicates a loss of fat mass. The increase in muscle mass 
increases the basal metabolic rate, which is responsible for up to two-thirds of total energy 
expenditure in healthy adults (39). In this scenario, the body fat percentage is relevant and the 
better indicator of a healthier metabolism (35). The example of body mass measurements 
illustrates the current paucity of data that can be equivocally compared now or with future 
results. More research is needed to develop a solid knowledge base and determine relationships 
between variables.   
  
RT protocols were detailed in each intervention, with each program significantly differing in 
terms of load, frequency, intensity, and supervision, indicating that the state of the science is still 
in an exploratory phase. However, each RT program was associated with reduced body fat as 
an outcome in women with PCOS, and primarily due to reduced abdominal adiposity. This 
outcome is promising, as a modest weight loss of 5-10% of total body weight is likely to produce 
health benefits, such as improved insulin sensitivity and total cholesterol (41). Interestingly, 
findings from two studies indicated improved depressive symptom scores (22, 37), also a 
positive outcome for women with PCOS who have a high rate of depressive symptoms (44).   
 
Research that examines the hormonal response to RT does exist; however, most of the studies 
involve men or trained athletes (21). Several positive hormonal outcomes unique to RT have 
been documented, all of which create a cascade of events that support energy production, 
improved insulin sensitivity, and increased strength (3). A hypothesis still under investigation 
and of relevance to women with PCOS is the possible upregulation of androgen receptors due 
to RT (13). Although RT may or may not directly affect SHBG, two factors do increase SHBG, 
and both are positive outcomes of RT: reduced visceral adiposity and improved insulin 
resistance (38). An increase in SHBG helps bind the excess bioavailable testosterone (31). 
 
Overall, the effect of RT on the hormonal profiles of women with PCOS is mixed among the 
three interventions discovered during this scoping review. As such, it remains unknown at this 
time if RT can alter certain hormones. If RT does alter the hormone panel of women with PCOS, 
the variation of response to anaerobic stress would depend on exercise frequency and intensity 
and program duration. More research is necessary that targets a range of selected hormonal 
variables among larger samples of women with PCOS who complete more detailed RT 
programs.   
 
Additional useful data gleaned from the feasibility study by Vizza et al. (37) were the success of 
Facebook as a recruitment tool and the increased adherence with supervised exercise sessions. 
The researchers concluded that a randomized control trial of RT for women with PCOS would 
be feasible, as evidence reveals that this mode of exercise can elicit a therapeutic effect on a wide 
range of health outcomes. The authors noted challenges recruiting women with PCOS to 
participate in their feasibility study. However, the authors further stated that this challenge is 
expected in clinical research, especially in interventions that require behavioral change (37).   
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The geographic location of these studies included Brazil, Norway, and Australia. To date, the 
US has not been a site for research trials investigating RT as a therapeutic management strategy 
for PCOS in premenopausal women. Few studies have shown differences between geographical 
location or race; however, the existing data remains inconclusive as to significant differences in 
the prevalence of PCOS across geographical location, racial, or ethnic groups (42).  
  
Also inconclusive is the effect of culture on the perception of RT. In a qualitative study by 
Moghadam et al. (26), women of Persian descent expressed stigma-related concerns due to 
perceived masculine characteristics of PCOS and RT. Wright et al. (44) found the same sentiment 
among women with PCOS in the US about femininity, along with stigma associated with being 
overweight or obese. Myre et al. (27) examined barriers to RT among women without PCOS and 
found that these women also endorsed a masculine stereotype to RT. Additionally, women 
without PCOS, who were overweight or obese, described stigmatizing concerns due to body 
size (14). Many women with PCOS have both hirsutism and overweightness or obesity, leading 
them to avoidance of body-conscious activities and social situations (27). Stigma related to 
weight issues is a barrier to health-seeking behaviors (11). Further research is needed to discover 
innovative strategies to mitigate negative perceptions of RT and the harmful consequences of 
stigma-related stress.  
  
The evidence about the effects of RT on health outcomes for women with PCOS is largely 
preliminary, but positive, and none of the studies showed an absence of benefit. The nine 
identified articles that reported on studies involving RT to determine effects on health outcomes 
for women with PCOS were representative of only three interventions: a nonrandomized case 
control study (a parent study with six sub-studies), a small, randomized controlled trial, and a 
nonrandomized feasibility study. Except for one study (19), sample sizes were small, thus 
limiting the generalizability to the broader PCOS population. Although detailed protocols were 
described, robust trials are needed to determine the minimum dose of RT to produce optimal 
health outcomes, including the potential symptom management benefits and contribution 
toward risk reduction of other chronic diseases. Other limitations of these studies included no 
assessment of prior physical activity or nutrition and the use of indirect measures of insulin 
resistance (2, 19, 37). Additional research with adequately powered clinical trials are required to 
establish health benefits, answer research questions as to therapeutic dose, and discover 
sustainable behavioral change strategies for women with PCOS. Lastly, if RT is deemed 
appropriate and effective as a therapeutic treatment strategy for women with PCOS, further 
investigation of facilitators and barriers to exercise unique to women with PCOS is necessary. 
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